A Study in Adults to Test the Effects of Low Dose Thimerosal on Symptoms of COVID-19
Status:
Completed
Trial end date:
2021-02-28
Target enrollment:
Participant gender:
Summary
Clinical trial to compare sublingual low does thimerosal in adults that have symptoms of
SARS-CoV-2 Infection against placebo to show a difference in physical characteristics and
viral levels.
Phase:
Phase 2
Details
Lead Sponsor:
Beech Tree Labs, Inc.
Collaborators:
Curavit Clinical Research Norwich Clinical Research Associates Ltd.